Literature DB >> 31884198

Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry.

Katie L Thoren1, Marion Eveillard2, Patrick Chan2, Sital Doddi2, Sun Cho2, Kazunori Murata2.   

Abstract

We describe the use of MALDI-TOF mass spectrometry in the analysis of a suspected case of gamma heavy chain disease. The patient had an abnormal serum immunofixation result where a monoclonal gamma heavy chain band was present without a corresponding light chain. Analysis by MALDI-TOF mass spectrometry revealed large peaks in the spectrum following IgG-specific purification. The m/z values of the peaks were outside the expected range for normal heavy chains or light chains. Corresponding peaks were not present in mass spectra of the kappa- or lambda-specific purifications. MALDI-TOF MS confirmed the presence of a truncated heavy chain without associated light chains. This case report demonstrates the value of mass spectrometry in interpreting challenging cases such as the identification of heavy chain disease.
Copyright © 2019 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heavy chain disease; MALDI-TOF mass spectrometry; Monoclonal immunoglobulin

Mesh:

Year:  2019        PMID: 31884198      PMCID: PMC7046309          DOI: 10.1016/j.clinbiochem.2019.12.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  14 in total

1.  Case records of the Massachusetts General Hospital. Case 13-2008. A 46-year-old man with rheumatoid arthritis and lymphadenopathy.

Authors:  Nikhil C Munshi; Subba Digumarthy; Aliyah Rahemtullah
Journal:  N Engl J Med       Date:  2008-04-24       Impact factor: 91.245

2.  Broad Bands Observed in Serum Electrophoresis Should Not Be Taken Lightly.

Authors:  Matthieu C J Bosman; Rachel H P Schreurs; Laurens Nieuwenhuizen; Dirk L Bakkeren; Joannes F M Jacobs
Journal:  Clin Chem       Date:  2019-05       Impact factor: 8.327

3.  Heavy chain disease: our experience.

Authors:  Francesca Gulli; Cecilia Napodano; Krizia Pocino; Annarosa Cuccaro; Stefan Hohaus; Umberto Basile
Journal:  Clin Chem Lab Med       Date:  2017-11-27       Impact factor: 3.694

4.  Restricted IgG-Kappa and Free Alpha-Heavy-Chain Bands in an Asymptomatic 62-Year-Old Man.

Authors:  Min Yu; David E Bruns; Jerry A Katzmann; Lawrence M Silverman; David L Murray
Journal:  Clin Chem       Date:  2018-02       Impact factor: 8.327

Review 5.  Heavy chain diseases.

Authors:  Dietlind L Wahner-Roedler; Robert A Kyle
Journal:  Best Pract Res Clin Haematol       Date:  2005       Impact factor: 3.020

6.  The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.

Authors:  Paolo Milani; David L Murray; David R Barnidge; Mindy C Kohlhagen; John R Mills; Giampaolo Merlini; Surendra Dasari; Angela Dispenzieri
Journal:  Am J Hematol       Date:  2017-06-01       Impact factor: 10.047

7.  Gamma-heavy chain disease: review of 23 cases.

Authors:  Dietlind L Wahner-Roedler; Thomas E Witzig; Laura L Loehrer; Robert A Kyle
Journal:  Medicine (Baltimore)       Date:  2003-07       Impact factor: 1.889

8.  Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.

Authors:  John R Mills; Mindy C Kohlhagen; Surendra Dasari; Patrick M Vanderboom; Robert A Kyle; Jerry A Katzmann; Maria A V Willrich; David R Barnidge; Angela Dispenzieri; David L Murray
Journal:  Clin Chem       Date:  2016-08-18       Impact factor: 8.327

9.  Gamma heavy chain disease in a patient with rheumatoid arthritis--a laboratory evaluation.

Authors:  Wibke Johannis; Jenny Blommer; Andreas R Klatt; Joerg H Renno; Klaus Wielckens
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

10.  Two Cases of γ-Heavy Chain Disease and a Review of the Literature.

Authors:  I Ramasamy; Z Rudzki
Journal:  Case Rep Hematol       Date:  2018-08-12
View more
  1 in total

1.  Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report.

Authors:  David L Murray; Noemi Puig; Sigurdur Kristinsson; Saad Z Usmani; Angela Dispenzieri; Giada Bianchi; Shaji Kumar; Wee Joo Chng; Roman Hajek; Bruno Paiva; Anders Waage; S Vincent Rajkumar; Brian Durie
Journal:  Blood Cancer J       Date:  2021-02-01       Impact factor: 11.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.